https://www.selleckchem.com/pr....oducts/carfilzomib-p
No complications occurred. After a mean follow-up of 14±6 months, no recurrent VT was documented in 2/2 pts with baseline VT and a mean 84% reduction in PVC burden (31±13% vs 4±5% PVC/d; p=0,0027) was documented in others. CONCLUSION In pts with LVS-VAs arising from the inaccessible region and refractory to conventional RFA, an anatomical approach utilizing Bi-RFA from the LPC and opposite LVOT is an effective alternative approach. ETHNOPHARMACOLOGICAL RELEVANCE Medicinal Earths (MEs), natural aluminosilicate-based substances
Like
Comment
Share
